KORU Medical Systems Capital Expenditures (CapEx) Growth & History (KRMD)
KORU Medical Systems's capital expenditures (capex) was $932,517 for fiscal 2025.
View full KORU Medical Systems company overviewKORU Medical Systems annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $932,517 | −$364,910 | −28.13% |
| 2024 | 2024-12-31 | $1.3M | $514,478 | +65.71% |
| 2023 | 2023-12-31 | $782,949 | −$2.0M | −71.64% |
| 2022 | 2022-12-31 | $2.8M | $2.4M | +697.58% |
| 2021 | 2021-12-31 | $346,178 | −$574,426 | −62.40% |
| 2020 | 2020-12-31 | $920,604 | $719,430 | +357.62% |
| 2019 | 2019-12-31 | $201,174 | −$95,844 | −32.27% |
| 2018 | 2018-12-31 | $297,018 | $159,201 | +115.52% |
| 2017 | 2017-12-31 | $137,817 | — | — |
| 2016 | 2017-02-28 | $203,125 | $81,343 | +66.79% |
| 2015 | 2016-02-29 | $121,782 | −$469,631 | −79.41% |
| 2014 | 2015-02-28 | $591,413 | $402,727 | +213.44% |
| 2013 | 2014-02-28 | $188,686 | −$374,881 | −66.52% |
| 2012 | 2013-02-28 | $563,567 | $327,332 | +138.56% |
| 2011 | 2012-02-29 | $236,235 | $35,713 | +17.81% |
| 2010 | 2011-02-28 | $200,522 | — | — |
KORU Medical Systems quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $107,907 | $79,093 | +274.50% |
| Q1 2026 | 2026-03-31 | $46,163 | −$397,275 | −89.59% |
| Q4 2025 | 2025-12-31 | $407,782 | $364,215 | +835.99% |
| Q3 2025 | 2025-09-30 | $52,483 | −$1.0M | −95.16% |
| Q2 2025 | 2025-06-30 | $28,814 | −$95,470 | −76.82% |
| Q1 2025 | 2025-03-31 | $443,438 | $310,355 | +233.20% |
| Q4 2024 | 2024-12-31 | $43,567 | −$152,485 | −77.78% |
| Q3 2024 | 2024-09-30 | $1.1M | $871,976 | +411.99% |
| Q2 2024 | 2024-06-30 | $124,284 | $21,643 | +21.09% |
| Q1 2024 | 2024-03-31 | $133,083 | −$139,522 | −51.18% |
| Q4 2023 | 2023-12-31 | $196,052 | −$23,311 | −10.63% |
| Q3 2023 | 2023-09-30 | $211,651 | −$414,753 | −66.21% |
| Q2 2023 | 2023-06-30 | $102,641 | −$1.1M | −91.18% |
| Q1 2023 | 2023-03-31 | $272,605 | −$478,303 | −63.70% |
| Q4 2022 | 2022-12-31 | $219,363 | $174,905 | +393.42% |
| Q3 2022 | 2022-09-30 | $626,404 | $476,907 | +319.01% |
| Q2 2022 | 2022-06-30 | $1.2M | $1.1M | +1951.92% |
| Q1 2022 | 2022-03-31 | $750,908 | $655,431 | +686.48% |
| Q4 2021 | 2021-12-31 | $44,458 | $32,177 | +262.01% |
| Q3 2021 | 2021-09-30 | $149,497 | −$395,076 | −72.55% |
| Q2 2021 | 2021-06-30 | $56,746 | −$207,413 | −78.52% |
| Q1 2021 | 2021-03-31 | $95,477 | −$4,114 | −4.13% |
| Q4 2020 | 2020-12-31 | $12,281 | −$30,700 | −71.43% |
| Q3 2020 | 2020-09-30 | $544,573 | $453,459 | +497.68% |
| Q2 2020 | 2020-06-30 | $264,159 | $238,706 | +937.83% |
| Q1 2020 | 2020-03-31 | $99,591 | $57,965 | +139.25% |
| Q4 2019 | 2019-12-31 | $42,981 | −$66,031 | −60.57% |
| Q3 2019 | 2019-09-30 | $91,114 | −$3,707 | −3.91% |
| Q2 2019 | 2019-06-30 | $25,453 | −$63,587 | −71.41% |
| Q1 2019 | 2019-03-31 | $41,626 | $37,481 | +904.25% |
| Q4 2018 | 2018-12-31 | $109,012 | — | — |
| Q3 2018 | 2018-09-30 | $94,821 | $23,314 | +32.60% |
| Q2 2018 | 2018-06-30 | $89,040 | — | — |
| Q1 2018 | 2018-03-31 | $4,145 | −$58,376 | −93.37% |
| Q2 2017 | 2017-09-30 | $71,507 | $53,258 | +291.84% |
| Q1 2017 · Mar 31 | 2017-03-31 | $62,521 | — | — |
| Q3 2016 | 2016-11-30 | $13,493 | $7,266 | +116.69% |
| Q2 2016 · Sep 30 | 2016-09-30 | $18,249 | — | — |
| Q2 2016 · Aug 31 | 2016-08-31 | $30,891 | −$7,875 | −20.31% |
| Q1 2016 · Jun 30 | 2016-06-30 | $19,900 | — | — |
| Q1 2016 · May 31 | 2016-05-31 | $54,649 | −$6,695 | −10.91% |
| Q4 2015 | 2016-02-29 | $15,445 | −$23,908 | −60.75% |
| Q3 2015 | 2015-11-30 | $6,227 | −$148,266 | −95.97% |
| Q2 2015 | 2015-08-31 | $38,766 | −$267,374 | −87.34% |
| Q1 2015 | 2015-05-31 | $61,344 | −$30,083 | −32.90% |
| Q4 2014 | 2015-02-28 | $39,353 | −$2,425 | −5.80% |
| Q3 2014 | 2014-11-30 | $154,493 | $140,581 | +1010.50% |
| Q2 2014 | 2014-08-31 | $306,140 | $241,376 | +372.70% |
| Q1 2014 | 2014-05-31 | $91,427 | $23,195 | +33.99% |
| Q4 2013 | 2014-02-28 | $41,778 | $22,916 | +121.49% |
| Q3 2013 | 2013-11-30 | $13,912 | −$103,101 | −88.11% |
| Q2 2013 | 2013-08-31 | $64,764 | −$241,032 | −78.82% |
| Q1 2013 | 2013-05-31 | $68,232 | −$53,664 | −44.02% |
| Q4 2012 | 2013-02-28 | $18,862 | −$13,966 | −42.54% |
| Q3 2012 | 2012-11-30 | $117,013 | $2,282 | +1.99% |
| Q2 2012 | 2012-08-31 | $305,796 | $248,580 | +434.46% |
| Q1 2012 | 2012-05-31 | $121,896 | $90,436 | +287.46% |
| Q4 2011 | 2012-02-29 | $32,828 | — | — |
| Q3 2011 | 2011-11-30 | $114,731 | $101,668 | +778.29% |
| Q2 2011 | 2011-08-31 | $57,216 | — | — |
| Q1 2011 | 2011-05-31 | $31,460 | — | — |
| Q3 2010 | 2010-11-30 | $13,063 | — | — |
KORU Medical Systems capital expenditures (capex) trends
Over the last five fiscal years, KORU Medical Systems's capital expenditures (capex) increased from $920,604 to $932,517, a change of $11,913. The latest reported quarter, Q2 2026, shows $107,907.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review KORU Medical Systems source filings ↗